A newly published study in the Harm Reduction Journal takes a close look at how well fentanyl and xylazine test strips actually perform. The results are eye-opening. Strips from different manufacturers vary significantly in accuracy, some fail entirely under low light, and the results they produce are genuinely easy to misread without prior training. Taken together, the findings raise an important question that goes well beyond brand comparisons: just how much protection can a small paper strip realistically offer against one of the most unpredictable drug supplies in recorded history?

A Drug Supply More Dangerous Than Ever Before

To understand why this research matters, it helps to first understand what is actually circulating in the illicit drug supply today. Fentanyl, a synthetic opioid 50 times more potent than heroin and 100 times more potent than morphine, now accounts for the majority of drug overdose deaths across the United States. According to the CDC, fentanyl was involved in nearly 70 per cent of all overdose deaths in 2023. Unlike many other substances, it carries no taste, no smell, and no visible trace in a powder or pill. In practice, people have no reliable way of knowing it is there.

More recently, xylazine, a sedative originally developed for veterinary use, has emerged as a widespread adulterant. Starting in Philadelphia, it has since spread across the country. In contrast to fentanyl, xylazine does not respond to naloxone, the standard overdose reversal medication. It also causes severe skin ulcerations that require prolonged medical treatment. When xylazine and fentanyl appear together in a sample, the combination becomes even harder to anticipate and respond to.

It is against this backdrop that fentanyl and xylazine test strips have gained attention as a frontline tool. The new research from the University of California, San Francisco, offers the most detailed picture yet of how well that tool actually holds up.

How the Study Tested Drug Checking Test Strips

The research team, led by Alan H.B. Wu from the Department of Laboratory Medicine at UCSF, obtained six commercially available strips. Three targeted xylazine, from Shanghai Accurature Diagnostics, WPHM, and Co-Innovation BioTech. Three targeted fentanyl, from W.H.P.M., TiamJin Mingao, and China Med.

The team tested each set of drug checking test strips against laboratory-prepared drug standards across a wide range of concentrations. The aim was to identify the lowest level each strip could reliably detect. Additionally, the team assessed how the fentanyl strips responded to eight chemically related analogues. Finally, researchers evaluated strip readability under five different lighting conditions, ranging from bright daylight to a completely dark room.

The findings highlight significant gaps that deserve much wider attention.

Wide Performance Gaps Between Fentanyl and Xylazine Test Strips

The sensitivity differences between strips were considerable. Among the xylazine test strips, the best performer detected the drug at 50 ng/mL. However, another only registered a positive result at 250 ng/mL, five times higher. For fentanyl, the gap was even larger. The most sensitive strip detected the drug at 3.5 ng/mL, well below the 20 ng/mL all manufacturers stated on their packaging. In contrast, the least sensitive strip did not register a positive until 112 ng/mL, meaning dangerous concentrations of fentanyl could pass through undetected entirely.

Furthermore, this is not a new or isolated finding. A 2021 study by Bergh and colleagues found commercial fentanyl test strips performing five to ten times above their stated sensitivity, though inconsistently across products. Similarly, a 2024 study by Halifax and colleagues found that different production lots of the same brand ranged from 20 ng/mL to 200 ng/mL. In other words, the same strip purchased from a different batch could perform ten times worse, and there is currently no way for someone to know which lot they hold at the point of use.

The illicit drug supply adds yet another layer of complexity. Pure fentanyl rarely appears on its own. Analogues including acetylfentanyl, furanylfentanyl, and cyclopropylfentanyl commonly turn up alongside it. Consequently, this study found that drug checking test strips detect these analogues at different thresholds and with inconsistent results across brands. A strip that catches one analogue may still miss another at a concentration that poses serious risk.

Why Lighting Conditions Matter More Than Most People Realise

One of the more overlooked findings in this study concerns something as basic as light. The researchers tested strips under five conditions: full daylight indoors with windows, standard artificial lighting, a dark room with the door ajar, a dark room using only a mobile phone torch, and a completely dark room with the door closed.

Under the first four conditions, all three observers read the strips without difficulty. In the completely darkened room, however, not one observer from either product lot could produce a readable result. Every observer recorded an unreadable outcome across both testing lots.

This finding matters because fentanyl and xylazine test strips are frequently used in conditions far from ideal. Bathrooms, vehicles, and nighttime settings are all common examples. As the researchers themselves noted, testing in a nightclub or bar is simply not appropriate given these constraints. In precisely the environments where these strips are most likely to be reached for, they may produce no usable result at all.

How Easily Drug Checking Test Strips Can Be Misread

Even under good lighting, the results of fentanyl and xylazine test strips require careful interpretation. These strips work in the opposite direction to most familiar rapid tests. With a pregnancy test or a COVID-19 antigen test, two lines signal a positive outcome. With drug checking test strips, however, two lines mean the target substance was not detected. One line in the control zone only indicates a positive detection.

This reversal creates a genuine and well-documented risk of misinterpretation. A faint line in the test zone, the kind that appears near the lower limits of detection, actually signals a negative result for the drug. Without proper instruction, someone holding that strip could read the faint line as a warning and draw the wrong conclusion entirely.

The researchers identify this as a critical gap. Users should always read results within the manufacturer’s recommended time window. Never use line intensity as a guide, since the test zone line always appears fainter than the control zone regardless of the result. Laboratory-grade methods such as Raman spectroscopy and mass spectrometry remain the acknowledged gold standard for drug identification. Most people, however, cannot access them outside clinical or forensic settings.

What This Research Tells Us About the Limits of Detection

The study is a genuinely useful piece of research. It provides clear comparative data on strip performance and highlights real-world limitations that previous evaluations had not fully addressed. For public health professionals, educators, and community organisations, the findings offer important context for conversations about drug-related risk.

What the data collectively shows is that the illicit drug supply has outpaced the tools available to assess it at the point of use. Fentanyl and xylazine test strips can detect the presence of a substance under the right conditions. Even so, no strip can identify every adulterant in a sample, account for concentration variations between batches, or be read reliably in the dark. Beyond that, no strip can reverse what happens once a substance enters the body.

Understanding these limitations is not a reason to dismiss the research. Rather, it is a reason to take seriously how much the drug supply has changed and how inadequate any single point-of-use tool is as a response to that change. The 112,000 overdose deaths recorded in the United States in 2023 were not the result of people ignoring warnings. In many cases, those individuals simply had no idea what was in the substances they used.

What Awareness and Education Can Do That Test Strips Cannot

For communities, schools, families, and anyone working in prevention or public health, the most valuable takeaway from this research is not which brand of strip performs best. Instead, it is the picture the data paints of just how complex and unpredictable the current drug environment has become.

Fentanyl and xylazine test strips represent one narrow attempt to introduce some certainty into a supply chain that operates entirely outside any quality or safety standard. In practice, they sometimes work and sometimes do not. Moreover, correct use requires good light, proper technique, prior training, and awareness of which production lot is in hand. Even then, each strip only tests for one or two substances in a sample that may contain many more.

Ultimately, awareness of what these strips can and cannot do carries real value. It reinforces a broader truth that no tool, test, or strategy operating at the point of use can fully substitute for understanding the risks before any exposure occurs. That kind of understanding remains one of the most powerful protective factors available, and it costs nothing to share.

Source: springer